Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Open-Label Study of INCB050465 in Autoimmune Hemolytic Anemia
2017-003652-22Phase 2Completed
- Sponsor
- Incyte
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of parsaclisib in autoimmune haemolytic anaemia (AIHA), sponsored by Incyte. Primary endpoint: Complete response rate between Week 6 and Week 12. Started Mar 2018; status: completed.
02
Drugs
parsaclisib
03
Conditions
autoimmune haemolytic anaemia (AIHA)
Beyond the preview
Go deeper on 2017-003652-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003652-22.